MARIMED INC. (MRMD) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
50/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseMRMD / S&P 1.45% / 15.20% |
LoseMRMD / S&P 4.37% / 15.00% |
LoseMRMD / S&P 33.33% / 50.40% |
| 2026-Q10/3 |
LoseMRMD / S&P -26.60% / -4.33% |
LoseMRMD / S&P 2.22% / 11.30% |
LoseMRMD / S&P 0.00% / 27.70% |
| 2025-Q41/3 |
LoseMRMD / S&P -36.91% / 2.65% |
LoseMRMD / S&P 1.21% / 9.00% |
WinMRMD / S&P 50.00% / 13.40% |
| 2025-Q32/3 |
WinMRMD / S&P 115.94% / 8.12% |
LoseMRMD / S&P -0.47% / 4.61% |
WinMRMD / S&P 100.00% / 13.45% |
| 2025-Q20/3 |
LoseMRMD / S&P -26.60% / 10.94% |
LoseMRMD / S&P 0.57% / 4.83% |
LoseMRMD / S&P 0.00% / 10.63% |
| 2025-Q10/3 |
LoseMRMD / S&P -18.97% / -4.27% |
LoseMRMD / S&P 3.77% / 4.98% |
LoseMRMD / S&P 0.00% / 10.57% |
| 2024-Q41/3 |
LoseMRMD / S&P -32.56% / 2.41% |
WinMRMD / S&P 6.27% / 5.25% |
LoseMRMD / S&P -33.33% / 6.15% |
| 2024-Q31/3 |
LoseMRMD / S&P -4.97% / 5.89% |
WinMRMD / S&P 8.48% / 5.89% |
LoseMRMD / S&P -300.00% / 6.11% |
| 2024-Q21/3 |
LoseMRMD / S&P -31.44% / 4.28% |
WinMRMD / S&P 10.97% / 5.38% |
LoseMRMD / S&P -200.00% / 5.12% |
| 2024-Q11/3 |
LoseMRMD / S&P -4.00% / 10.56% |
WinMRMD / S&P 10.97% / 5.71% |
LoseMRMD / S&P -200.00% / 5.59% |
| 2023-Q41/3 |
LoseMRMD / S&P -36.93% / 11.69% |
WinMRMD / S&P 10.89% / 6.81% |
LoseMRMD / S&P -175.00% / 7.78% |
| 2023-Q32/3 |
WinMRMD / S&P 6.34% / -3.27% |
WinMRMD / S&P 12.62% / 7.52% |
LoseMRMD / S&P MRMD unavailable / -5.03% |
| 2023-Q20/3 |
LoseMRMD / S&P 4.33% / 8.74% |
LoseMRMD / S&P 9.43% / 9.50% |
LoseMRMD / S&P MRMD unavailable / -8.57% |
| 2023-Q12/3 |
WinMRMD / S&P 10.39% / 7.50% |
LoseMRMD / S&P 7.03% / 10.77% |
WinMRMD / S&P 50.00% / -15.69% |
| 2022-Q41/3 |
LoseMRMD / S&P -17.78% / 7.56% |
LoseMRMD / S&P 10.33% / 11.88% |
WinMRMD / S&P 100.00% / -17.99% |
| 2022-Q31/3 |
LoseMRMD / S&P -7.87% / -4.88% |
WinMRMD / S&P 16.65% / 13.47% |
LoseMRMD / S&P -100.00% / -1.41% |
| 2022-Q21/3 |
LoseMRMD / S&P -35.62% / -16.10% |
WinMRMD / S&P 41.18% / 13.71% |
LoseMRMD / S&P -100.00% / 11.04% |
| 2022-Q11/3 |
LoseMRMD / S&P -15.61% / -4.60% |
WinMRMD / S&P 88.19% / 15.97% |
LoseMRMD / S&P -33.33% / 42.23% |
| 2021-Q42/3 |
LoseMRMD / S&P -3.89% / 11.03% |
WinMRMD / S&P 138.66% / 15.00% |
WinMRMD / S&P 100.00% / 96.40% |
| 2021-Q31/3 |
LoseMRMD / S&P -4.66% / 0.58% |
WinMRMD / S&P 71.06% / 10.77% |
LoseMRMD / S&P -115.50% / 69.42% |
| 2021-Q22/3 |
WinMRMD / S&P 21.03% / 8.55% |
WinMRMD / S&P 64.00% / 6.58% |
LoseMRMD / S&P -111.88% / 51.81% |
| 2021-Q12/3 |
WinMRMD / S&P 65.96% / 6.17% |
WinMRMD / S&P 37.37% / -1.06% |
LoseMRMD / S&P -107.48% / 7.39% |
| 2020-Q42/3 |
WinMRMD / S&P 191.93% / 12.15% |
WinMRMD / S&P 11.60% / -3.72% |
LoseMRMD / S&P MRMD unavailable / -33.42% |
| 2020-Q31/3 |
LoseMRMD / S&P 2.55% / 8.93% |
WinMRMD / S&P 336.89% / -2.04% |
LoseMRMD / S&P MRMD unavailable / -27.10% |
| 2020-Q21/3 |
LoseMRMD / S&P -11.30% / 20.54% |
WinMRMD / S&P 296.33% / -0.46% |
LoseMRMD / S&P MRMD unavailable / -27.11% |
| 2020-Q11/3 |
LoseMRMD / S&P -71.36% / -19.60% |
WinMRMD / S&P 273.02% / 3.47% |
LoseMRMD / S&P MRMD unavailable / -14.75% |
| 2019-Q41/3 |
LoseMRMD / S&P -38.20% / 9.07% |
WinMRMD / S&P 284.79% / 5.36% |
LoseMRMD / S&P MRMD unavailable / 2.99% |
| 2019-Q31/3 |
LoseMRMD / S&P -50.50% / 1.70% |
WinMRMD / S&P 48.35% / 5.02% |
LoseMRMD / S&P MRMD unavailable / 0.21% |
| 2019-Q21/3 |
LoseMRMD / S&P -42.29% / 4.30% |
WinMRMD / S&P 68.41% / 6.64% |
LoseMRMD / S&P MRMD unavailable / 8.65% |
| 2019-Q11/3 |
LoseMRMD / S&P 7.69% / 13.65% |
WinMRMD / S&P 89.78% / 8.12% |
LoseMRMD / S&P MRMD unavailable / 14.29% |
| 2018-Q42/3 |
WinMRMD / S&P -13.33% / -13.52% |
WinMRMD / S&P 95.32% / 9.05% |
LoseMRMD / S&P MRMD unavailable / 18.23% |
| 2018-Q32/3 |
WinMRMD / S&P 62.34% / 7.71% |
WinMRMD / S&P 68.90% / 10.21% |
LoseMRMD / S&P MRMD unavailable / 19.06% |
| 2018-Q22/3 |
WinMRMD / S&P 104.42% / 3.43% |
WinMRMD / S&P 63.90% / 9.03% |
LoseMRMD / S&P MRMD unavailable / 14.46% |
| 2018-Q12/3 |
WinMRMD / S&P 63.77% / -0.76% |
WinMRMD / S&P 70.72% / 7.68% |
LoseMRMD / S&P MRMD unavailable / 12.46% |
| 2017-Q42/3 |
WinMRMD / S&P 50.33% / 6.64% |
WinMRMD / S&P 70.25% / 7.03% |
LoseMRMD / S&P MRMD unavailable / 13.82% |
| 2017-Q31/3 |
LoseMRMD / S&P -27.14% / 4.48% |
WinMRMD / S&P 106.71% / 5.68% |
LoseMRMD / S&P MRMD unavailable / 17.57% |
| 2017-Q22/3 |
WinMRMD / S&P 125.00% / 3.09% |
WinMRMD / S&P 113.07% / 4.83% |
LoseMRMD / S&P MRMD unavailable / 17.74% |
| 2017-Q12/3 |
WinMRMD / S&P 19.15% / 6.07% |
WinMRMD / S&P 129.28% / 3.67% |
LoseMRMD / S&P MRMD unavailable / 13.32% |
| 2016-Q42/3 |
WinMRMD / S&P 88.00% / 3.82% |
WinMRMD / S&P 180.60% / 2.09% |
LoseMRMD / S&P MRMD unavailable / 7.05% |
| 2016-Q31/3 |
LoseMRMD / S&P -10.71% / 3.85% |
WinMRMD / S&P 353.37% / 0.20% |
LoseMRMD / S&P MRMD unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | MRMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -42.21% | 20.78% |
| Annualized return | -42.21% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | MRMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.86% | 83.14% |
| Annualized return | -38.03% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | MRMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -25.83% | 319.30% |
| Annualized return | -2.94% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.